Search Results - "Minze, Molly G."

Benefits of SGLT2 Inhibitors Beyond Glycemic Control - A Focus on Metabolic, Cardiovascular and Renal Outcomes by Minze, Molly G, Will, Kayley J, Terrell, Brian T, Black, Robin L, Irons, Brian K

“…Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a new pharmacotherapeutic class for the treatment of Type 2 Diabetes Mellitus (T2DM). To evaluate…”
Get more information

An Evaluation of Nonacademic Predictors of Success in a Doctor of Pharmacy Program by Mahan, Rebecca J., Mathys, Monica, Minze, Molly G., Sherrod, Sonya E., Seifert, Charles F.

“…Objective. Pharmacy programs have struggled to predict who will be successful in their programs based solely on cognitive skills. The primary objective of this…”
Get full text

An Evaluation of Nonacademic Predictors of Success in a Doctor of Pharmacy Program by Seifert, Charles F, Mahan, Rebecca J, Mathys, Monica, Minze, Molly G, Sherrod, Sonya E

“…Objective. Pharmacy programs have struggled to predict who will be successful in their programs based solely on cognitive skills. The primary objective of this…”
Get full text

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults by Minze, Molly G., Klein, Mary S., Terrell, Brian T.

“…Type 2 diabetes affects millions of people worldwide and significantly contributes to morbidity and mortality of those affected by it. Current guidelines…”
Get full text

Envisioning the Future of Student Success: Report of the 2022–2023 AACP Student Affairs Standing Committee by Robinson, Evan T., Cochrane, Zara Risoldi, Akiyode, Oluwaranti, Chahine, Elias B., Culhane, James M., Do, Duc P., Franson, Kari L., Minze, Molly G., Ross, Libby J.

“…Over the past several years, traditional metrics have indicated declining student success within colleges and schools of pharmacy. Though students may be less…”
Get full text

Achieving cholesterol goals with low-cost 3-hydroxy-3-methylglutaryl coenzyme-A (HMG Co-A) reductase inhibitors by Klein, Mary S, Koffarnus, Robin L, Minze, Molly G, Ochoa, Pamella

“…OBJECTIVE.The objective of this study was to determine the efficacy of widely available low-cost generic statins in achieving NCEP/ATP III cholesterol goals in…”
Get full text

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated by Irons, Brian K, Minze, Molly G

“…Metformin is considered an initial drug of choice for type 2 diabetes mellitus by leading recommendations. When contraindications to its use exist or patients…”
Get full text

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes by Edwards, Krystal L, Minze, Molly G

“…As the prevalence of type 2 diabetes mellitus (T2DM) is anticipated to continue to rise worldwide, so too are the treatment options also continuing to expand…”
Get full text

Once-Weekly Exenatide: An Extended-Duration Glucagon-Like Peptide Agonist for the Treatment of Type 2 Diabetes Mellitus by Minze, Molly G., Klein, Mary S., Jernigan, Michelle J., Wise, Stephen L., Frugé, Kristian

“…Type 2 diabetes affects over 25 million people in the United States. There are many treatment options for patients with type 2 diabetes, but current treatments…”
Get full text

Removing barriers to insulin use by Minze, Molly G, Dalal, Kavita, Irons, Brian K

“…Patients with type 2 diabetes and their physicians are often reluctant to begin insulin therapy--despite evidence of its efficacy. Here's help in overcoming…”
Get full text

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide by Minze, Molly G, Chastain, Lisa M

“…The global burden of type 2 diabetes is estimated to currently affect over 350 million people worldwide and is anticipated to continue increasing over the next…”
Get full text

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue? by Minze, Molly G., Kwee, Yu-Yu, Hall, Ronald G.

“…Objective. To evaluate the pharmacokinetic, safety, and effectiveness data of dosing low-molecular-weight heparins (LMWHs) for prophylaxis of venous…”
Get full text

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes by Edwards, Krystal, Minze, Molly

Get full text

Guidelines for therapeutic interchange—2022 by Welty, Timothy E., Hilaire, Michelle L., Frantzen, Leah M., Achey, Thomas S., Minze, Molly G., Japs, Kelsey L., Elliott, Amber N., Brasher, Cynthia A., May, Dianne W., Mosley, Scott A., Johnson, Corinne G., Grimm, Derek L., Huffman, Sara

“…The American College of Clinical Pharmacy (ACCP) Board of Regents charged the 2020 to 2021 Publications Committee to review and revise the 2004 ACCP guideline…”
Get full text

Removing barriers to insulin use: patients with type 2 diabetes and their physicians are often reluctant to begin insulin therapy - despite evidence of its efficacy. Here's help in overcoming this other form of "insulin resistance." by Minze, Molly G, Dalal, Kavita, Irons, Brian K

Get full text

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum] by Irons, Brian, Minze, Molly

“…Irons BK, Minze MG. Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated. Diabetes Metab Syndr Obes. 2014;7:15-24.There…”
Get full text

PRN OPINION PAPER: Application of precision medicine across pharmacy specialty areas by Caudle, Kelly E., Gammal, Roseann S., Karnes, Jason H., Afanasjeva, Janna, Anderson, Keri C., Barreto, Erin F., Beavers, Craig, Bhat, Shubha, Birrer, Kara L., Chahine, Elias B., Ensor, Christopher R., Flowers, Stephanie A., Formea, Christine M., George, Jomy M., Gosser, Rena A., Hebert, Mary F., Karaoui, Lamis R., Kolpek, Jimmi Hatton, Lee, James C., Leung, Jonathan G., Maldonado, Angela Q., Minze, Molly G., Pulk, Rebecca A., Shelton, Chasity M., Sheridan, Maria, Smith, Michael A., Soefje, Scott, Tellez‐Corrales, Eglis, Walko, Christine M., Cavallari, Larisa H.

“…Clinical pharmacists have been incorporating precision medicine into practice for decades. Drug selection and dosing based on patient‐specific clinical factors…”
Get full text

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults by Molly G. Minze, Mary S. Klein, Brian T. Terrell

“…Type 2 diabetes affects millions of people worldwide and significantly contributes to morbidity and mortality of those affected by it. Current guidelines…”
Get full text